Rules differ by market
The EU does not yet require aggregation, but the UAE and Saudi Arabia do. What works in one market is not enough in the next.
Serialization as a Service
Independent advice for pharma companies selling in Europe and the Middle East.
Serialization compliance, explained and led by someone who runs it for a global biotech.
Independent advice, not software. I help you decide and plan; specialist partners handle the technical set-up.
The problem
The EU does not yet require aggregation, but the UAE and Saudi Arabia do. What works in one market is not enough in the next.
Who does what between you, your distributor, your 3PL and your CMO is often not written down. Or written down differently by each party.
Many gaps only surface at launch or during an audit, when fixing them is slow and expensive.
Services
from €3,900
A gap check against the rules of your markets and a prioritised action plan.
What you receive
from €2,250 per country
What the country requires, who must do what, key deadlines, and next steps.
What you receive
from €1,450
What serialization points to cover with your 3PL, CMO or distributor, in plain language. (Not legal advice.)
What you receive
€150/houror 10-hour monthly retainer at €1,400
An on-call senior sounding board for serialization and the pharma supply chain around it.
What you receive
Fixed price, fixed scope, one review round included. Prices exclude VAT. Larger or multi-country programmes: ask for a quote.
I take on a limited number of engagements at a time. Timing is agreed at the intro call.
Advisory only, short fixed-scope engagements. Larger programmes on request.
Need technical set-up or system configuration? I coordinate trusted specialist partners and stay your independent advisor.
How it works
Free. We look at your situation and whether I can help.
You receive a clear scope and a fixed price.
I do the work, then we review it together in one session.
A document you can act on and share with your team.
Markets
Falsified Medicines Directive and Delegated Regulation 2016/161, the EMVS, and national differences.
Explainer coming soon
The national track-and-trace system and what it means for you and your distributor.
Explainer coming soon
Saudi FDA requirements for drug track and trace, and who must report what.
Explainer coming soon
Other markets on request.
Free tools
Answer five short questions and see what generally applies in your markets.
Tick what applies in about two minutes. No writing needed.

About
Independent BioPharma supply chain consultant
I am an independent BioPharma supply chain consultant with 35 years in supply chain and logistics, more than 12 of them in BioPharma.
I have led serialization implementation, 3PL network transformation and GMP/GDP governance improvements, and selected contract packagers, warehouses and wholesalers across Europe.
I have been the hands-on TraceLink administrator for four biopharma companies and handled NMVO contracting for those same companies. So I know what technical teams actually need from the business.
Since 2019 I have worked with 13 pharma and biotech companies. I started my career as a logistics officer in the Royal Netherlands Navy, which shaped a disciplined, risk-aware way of working.
Contact
Book a free 20-minute call, or send a short message.